BioInc@NYMC

BioInc@NYMC is the NY Hudson Valley's only biotech incubator on a health science college campus offering shared resources and turn-key wet lab space.

[BioInc@NYMC @BioIncNYMC]

Register now for the upcoming conference on innovation! See what colleagues are doing about STEM outreach and entrepreneurship with us and @WestchesterBio on Nov. 28!

https://t.co/yMkLmCz5fY

[BioInc@NYMC @BioIncNYMC]

“Across the county, life-science businesses that put down roots in Westchester are thriving– and making waves nationally.” https://t.co/YHew7Xl5eO

[BioInc@NYMC @BioIncNYMC]

Are you ready to find a home for your #biotech start up? #STEM #Entrepreneur #lifesciences https://t.co/d3SpLtJuyL

[BioInc@NYMC @BioIncNYMC]

“Retia’s MBA algorithm offers consistently accurate #cardiac output measurements by analyzing multiple #heartbeats for each cardiac output calculation," co-founder & CEO of Retiamedical & BioInc@NYMC client Marc Zemel, S.M., M.B.A. https://t.co/L5JvWKpys8 #BioInc #NYMC #biotech

[BioInc@NYMC @BioIncNYMC]

BioInc client Barry Kappel PhD, MBA, president and CEO of Sapience Therapeutics, receives NIH grant to help develop a new approach to combatting #coronaviruses like the #SARSCoV2 virus that causes #COVID19. https://t.co/bxZdltQRWl #NYMC #research #biotech #medtech #HealthTech

[BioInc@NYMC @BioIncNYMC]

BioInc client Sapience Therapeutics awarded @NIH grant for #research on developing #cancer treatments. https://t.co/3LE7PArV2n #BioInc #NYMC #biotech #NIH

[BioInc@NYMC @BioIncNYMC]

#BioInc listed as part of county’s largest bioscience cluster. https://t.co/nfEMQj1Wrz #NYMC #medtech #biotech #biotechnology #healthtech #incubator #research #startup

[BioInc@NYMC @BioIncNYMC]

BioInc, mid-Hudson Valley’s only fully-equipped biotechnology incubator on a health sciences college campus, is recognized as one of Westchester's #biotech #startup. https://t.co/DoADxFhX5C #BionInc #NYMC #medtech #healthtech

[BioInc@NYMC @BioIncNYMC]

Downloads for @medisprout #telemedicine app, a BioInc@NYMC (BioInc at NYMC) client, increased a staggering 8,270% in second quarter of 2020. https://t.co/iBXAC9BPaE #BioInc #NYMC #socialmedia #COVID19

[BioInc@NYMC @BioIncNYMC]

"The ability to distribute a CE-marked Argos Monitor is an important step in advancing care for high-risk patients," BioInc client and co-founder and CEO of Retia Medical Marc Zemel, S.M., M.B.A. https://t.co/aJPq4kBiNl #NYMC #BioInc #ArgosMonitor #Retia

[BioInc@NYMC @BioIncNYMC]

"Taking a break from social media, even for brief periods, can help lessen your anxieties & stave off the loneliness that many feel when surfing their channels,” BioInc client and CEO/founder of @medisprout Samant Virk. https://t.co/SzlLRvE9d1 #BioInc #NYMC #socialmedia #COVID19

[BioInc@NYMC @BioIncNYMC]

A one-on-one interview with BioInc@NYMC client & @medisprout CEO Samant Virk, M.D., on how his company connects #healthcare #providers with #telehealth solutions during the #COVID19 crisis. https://t.co/N6qmvi3KNA #Biotech #Medtech #BioInc #NYMC #healthtech #telemedicine

[Sweet Defeat @sweetdefeat]

Did you know that Sweet Defeat is clinically proven to reduce sugar intake by 50%? 🍩🍬🧁⁠
https://t.co/Awq3JCVAlR

[MediSprout @medisprout]

Interesting opinion piece in the The Boston Globe today about how Congress should make sure #telemedicine is here to stay!
https://t.co/0cb89AYbv7

[MediSprout @medisprout]

New coverage from our CEO and Founder, Dr. Sam Virk, on the top questions that practices should ask when looking at #telehealth solutions. Check it out here: Telehealth solutions: Top questions for physician practices to consider https://t.co/gfNGCJQqpf via
@PhysiciansPract

[BioInc@NYMC @BioIncNYMC]

BioIncNYMC client & @medisprout CEO Samant Virk, MD, emphasizes the importance of #physicians staying connected with #patients through #virtual visits during the #coronavirus pandemic. https://t.co/eyJBzEussi #Biotech #Medtech #BioInc #NYMC #Telehealth #healthtech #telemedicine

[BioInc@NYMC @BioIncNYMC]

.@BioIncNYMC client Sapience Therapeutics will present preclinical data on intracellular pathways as drug targets. https://t.co/vUS1kpg4E6 #BioInc #NYMC #biotech #medtech #healthtech

[BioInc@NYMC @BioIncNYMC]

"Telehealth is now becoming the #newnormal within our health care system," BioInc@NYMC client and @medisprout CEO Samant Virk, M.D. https://t.co/Krj2DBoF46 #Biotech #Medtech #BioInc #NYMC #Coronavirus #COVIDPandemic

[BioInc@NYMC @BioIncNYMC]

“People don’t have to travel, take time from work and sit in a waiting room," BioInc@NYMC client and @medisprout CEO Samant Virk, M.D. https://t.co/ESZwl9od8n #biotech #medtech #BionInc #NYMC

[BioInc@NYMC @BioIncNYMC]

BioInc@NYMC client and @medisprout CEO Samant Virk, M.D. explains how telemedicine & telehealth are crucial for patients in far-reaching geographic locations with minimal travel. https://t.co/8Qv8p7WF8k #biotech #medtech #BionInc #NYMC #Coronavirus #2019nCov #CoVid19